Research
Quality of Life in PSC Study Recruiting Now
Recruiting now
Read MoreFebruary 2025 Research Roundup
Read a research update from Martine Walmsley for February 2025.
Read MoreNew Phase 3 Trial Planned for Nebokitug in PSC
A new trial is planned for PSC
Read MoreSPRING Clinical Trial Update
Clinical Data from Phase 2 SPRING Trial Shows CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of PSC.
Read MorePromising Preclinical Data from Rectify Pharma
Rectify Pharma presented promising preclinical data for RTY-694, their lead candidate for treating primary sclerosing cholangitis and other hepatobiliary diseases, at the 75th Annual Liver Meeting® 2024.
Read MoreIs the Asp-PSC Study Open Near You?
Sign up for an alert when the Asp-PSC Study is recruiting near you.
Read MoreNGM Bio Announces Plans for a New Clinical Trial
NGM Bio has announced plans for a new clinical trial to evaluate a medicine called aldafermin in PSC.
Read MorePositive Results Announced from SPRING Trial
Positive results from the SPRING Clinical Trial announced today
Read MoreFirst Participant in FARGO Trial
A PSC Support Trustee has been diagnosed with both PSC and inflammatory bowel disease (IBD). They is receiving weekly poo transplants to treat the conditions in a world first trial.
Read MoreMore Encouraging Data from the INTEGRIS Clinical Trial
Pliant Therapeutics announce latest results from the INTEGRIS Clinical Trial
Read More